Back to top

Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following ...

Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBE

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Vivani Medical, Inc. (VANI)